Wolverine Trading LLC Buys Shares of 7,064 Option Care Health, Inc. (NASDAQ:OPCH)

Wolverine Trading LLC purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 7,064 shares of the company’s stock, valued at approximately $222,000.

A number of other institutional investors have also made changes to their positions in OPCH. Blue Trust Inc. lifted its stake in Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after buying an additional 377 shares during the period. Raymond James & Associates raised its position in shares of Option Care Health by 49.5% in the 2nd quarter. Raymond James & Associates now owns 80,230 shares of the company’s stock valued at $2,222,000 after acquiring an additional 26,560 shares during the period. Nisa Investment Advisors LLC grew its holdings in Option Care Health by 5.4% during the second quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock valued at $376,000 after purchasing an additional 690 shares during the period. MeadowBrook Investment Advisors LLC increased its stake in Option Care Health by 36.1% in the second quarter. MeadowBrook Investment Advisors LLC now owns 6,610 shares of the company’s stock valued at $183,000 after purchasing an additional 1,755 shares in the last quarter. Finally, Nicholas Company Inc. raised its holdings in Option Care Health by 7.0% in the second quarter. Nicholas Company Inc. now owns 234,000 shares of the company’s stock worth $6,482,000 after purchasing an additional 15,320 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.64% of the company’s stock.

Option Care Health Price Performance

NASDAQ OPCH opened at $23.49 on Monday. The firm’s 50 day moving average is $25.40 and its 200-day moving average is $28.46. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $4.00 billion, a PE ratio of 19.74, a price-to-earnings-growth ratio of 2.45 and a beta of 1.33. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.63.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several research analyst reports. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. UBS Group assumed coverage on Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target for the company. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Barrington Research lowered their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Finally, Truist Financial cut their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health has an average rating of “Hold” and an average price target of $30.14.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.